|
시장보고서
상품코드
2075269
안드로겐 보충 요법 시장 : 제품 유형별, 유효 성분별, 유통 채널별 및 지역별Androgen Replacement Therapy Market, By Product Type, By Active Ingredient, By Distribution Channel, and By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
안드로겐 보충 요법 시장은 2026년에 28억 5,780만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 48억 9,770만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 28억 5,780만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.00% | 2033년 시장 규모 예측 : | 48억 9,770만 달러 |
안드로겐 대체요법(ART)은 흔히 테스토스테론 대체요법(TRT)이라고도 불리며, 안드로겐(대부분 테스토스테론)을 보충하는 화학요법의 일종입니다. 남성 성선 기능 저하증의 영향을 해결하기 위해 ART가 자주 처방됩니다. 일반적으로 테스토스테론은 주사, 피부용 크림, 패치, 젤 또는 피하 펠릿의 형태로 투여됩니다. 테스토스테론 보충 요법은 성선 기능 저하증의 증상을 개선하고 테스토스테론 수치를 높이기 위한 유망한 치료법입니다. 또한 테스토스테론 보충 요법의 적용과 관련된 이점으로는 근육량 증가, 전반적인 활력 향상, 우울 증상의 현저한 완화 등이 있습니다.
시장 역학
안드로겐 대체요법 시장은 제약사 간의 합병 및 인수(M&A) 증가로 인해 예측 기간 중 성장이 예상됩니다. 예를 들어 2022년 10월, 미국에 본사를 둔 의약품 연구개발·제조·판매 기업인 Tolmar Inc.는 Clarus Therapeutics Holdings, Inc. 및 그 완전 자회사인 Clarus Therapeutics, Inc.(희귀 질환의 잠재적 치료법을 포함하여, 남성과 여성을 위한 안드로겐 요법 및 대사 요법 개발을 전문으로 하는 제약 회사)로부터 경구용 소프트젤 제형 테스토스테론 제제 ‘JATENZO'의 모든 권리를 취득했다고 발표했습니다. 공개 입찰을 통해 이루어졌습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수를 바탕으로 전 세계 안드로겐 보충 요법 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 사항 및 전략, 그리고 향후 계획입니다.
- 이 보고서에서 얻을 수 있는 인사이트는 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내릴 수 있도록 해줍니다.
- 이 세계의 안드로겐 보충 요법 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 안드로겐 보충 요법 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 안드로겐 보충 요법 시장 : 제품 유형별, 2021-2033년
제5장 세계의 안드로겐 보충 요법 시장 : 유효 성분별, 2021-2033년
제6장 세계의 안드로겐 보충 요법 시장 : 유통 채널별, 2021-2033년
제7장 세계의 안드로겐 보충 요법 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.08Androgen Replacement Therapy Market is estimated to be valued at USD 2,857.8 Mn in 2026 and is expected to reach USD 4,897.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,857.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 4,897.7 Mn |
Androgen substitution treatment (ART), frequently refered to as testosterone substitution treatment (TRT), is a type of chemical treatment, wherein androgens, frequently testosterone, are supplanted. In order to combat the effects of male hypogonadism, ART is frequently prescribed. Typically, testosterone is administered via injection, skin cream, patch, gel, or subcutaneous pellet form. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level. Furthermore, benefits related to application of testosterone replacement therapy include an increase in muscle tissue, overall surge in energy, and significant decrease in depression symptoms.
Market Dynamics
The androgen replacement therapy market is expected to witness growth during the forecast period, owing to the increasing mergers and acquisitions among pharmaceutical companies. For instance, in October 2022, Tolmar Inc., a U.S-based pharmaceutical research, development, manufacturing and commercial operations company, announced the acquisition of all rights to JATENZO, an oral softgel testosterone medicine from Clarus Therapeutics Holdings, Inc. and its wholly-owned subsidiary Clarus Therapeutics, Inc.- a pharmaceutical company with specialization in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. following a public auction.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global androgen replacement therapy market based on the following parameters- company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include AbbVie, Inc., Bayer AG, Endo International plc, Lilly, Kyowa Kirin Co., Ltd, Novartis AG, Pfizer Inc, Clarus Therapeutics, Perrigo Company plc, Acerus Pharmaceuticals Corporation, Sawai Pharmaceutical Co.,Ltd, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd., and Simple Pharma.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global androgen replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global androgen replacement therapy market
Detailed Segmentation:
- Global Androgen Replacement Therapy Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Testosterone Creams/Gels
- Testosterone Patches
- Testosterone Injections
- Testosterone Implants
- Testosterone Tablets/Capsules/Gums
- Global Androgen Replacement Therapy Market, By Active Ingredient (Revenue, USD Mn, 2021 - 2033)
- Testosterone
- Methyl Testosterone
- Testosterone Undecanoate
- Testosterone Enanthate
- Testosterone Cypionate
- Global Androgen Replacement Therapy Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Androgen Replacement Therapy Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- AbbVie, Inc.
- Bayer AG
- Endo International plc
- Lilly
- Kyowa Kirin Co., Ltd.
- Novartis AG
- Pfizer Inc
- Clarus Therapeutics
- Perrigo Company plc
- Acerus Pharmaceuticals Corporation
- Sawai Pharmaceutical Co.,Ltd
- Reddy's Laboratories Ltd
- Sun Pharmaceutical Industries Ltd
- Simple Pharma
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Active Ingredient
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Androgen Replacement Therapy Market, By Product Type, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Testosterone Creams/Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Tablets/Capsules/Gums
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Androgen Replacement Therapy Market, By Active Ingredient , 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Methyl Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Undecanoate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Enanthate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Testosterone Cypionate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Androgen Replacement Therapy Market, By Distribution Channel, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Androgen Replacement Therapy Market, By Region, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Active Ingredient, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021- 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- AbbVie, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kyowa Kirin Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Clarus Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Perrigo Company plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Acerus Pharmaceuticals Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sawai Pharmaceutical Co.,Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Simple Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
